Application of population pharmacokinetic modeling in early clinical development of the anticancer agent E7820

Author： Keizer Ron Zamacona Miren Jansen Mendel Critchley David Wanders Jantien Beijnen Jos Schellens Jan Huitema Alwin

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.27, Iss.2, 2009-04, pp. : 140-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Integration of Physiologically‐Based Pharmacokinetic Modeling into Early Clinical Development: An Investigation of the Pharmacokinetic Nonlinearity

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 5, 2015-05 ,pp. : 286-294

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetic Drug–Drug Interaction of the Novel Anticancer Agent E7070 and Acenocoumarol

By van den Bongard H.J.G. Desirée Sparidans Rolf W. Critchley David J.P. Beijnen Jos H. Schellens Jan H.M.

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 151-158

Springer Publishing Company

Access to resources Recommend Favorite

HPLC-UV method development and validation for 16-dehydropregnenolone, a novel oral hypolipidaemic agent, in rat biological matrices for application to pharmacokinetic studies

By Singh S.K. Mehrotra N. Sabarinath S. Gupta R.C.

Journal of Pharmaceutical and Biomedical Analysis, Vol. 33, Iss. 4, 2003-11 ,pp. : 755-764

Elsevier

Access to resources Recommend Favorite

Indisulam: an anticancer sulfonamide in clinical development

By Supuran Claudiu T

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 283-287

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic Profiles of Anticancer Herbal Medicines in Humans and the Clinical Implications

Current Medicinal Chemistry, Vol. 18, Iss. 21, 2011-07 ,pp. : 3190-3210

Bentham Science Publishers

Access to resources Recommend Favorite